NDC 0008-1211

Pristiq Extended-Release

Desvenlafaxine Succinate

Pristiq Extended-Release is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.. The primary component is Desvenlafaxine Succinate.

Product ID0008-1211_0c40d9ea-730a-42d8-abd1-5a1da444dfb6
NDC0008-1211
Product TypeHuman Prescription Drug
Proprietary NamePristiq Extended-Release
Generic NameDesvenlafaxine Succinate
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2008-05-01
Marketing CategoryNDA / NDA
Application NumberNDA021992
Labeler NameWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Substance NameDESVENLAFAXINE SUCCINATE
Active Ingredient Strength50 mg/1
Pharm ClassesCytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0008-1211-01

90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-01)
Marketing Start Date2008-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0008-1211-70 [00008121170]

Pristiq Extended-Release TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021992
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-05-01
Marketing End Date2016-12-31

NDC 0008-1211-17 [00008121117]

Pristiq Extended-Release TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021992
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-03-18
Marketing End Date2015-03-25

NDC 0008-1211-40 [00008121140]

Pristiq Extended-Release TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021992
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-09-08
Marketing End Date2009-11-18

NDC 0008-1211-50 [00008121150]

Pristiq Extended-Release TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021992
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-05-01

NDC 0008-1211-80 [00008121180]

Pristiq Extended-Release TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021992
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-09-08
Marketing End Date2014-03-18

NDC 0008-1211-01 [00008121101]

Pristiq Extended-Release TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021992
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-05-01

NDC 0008-1211-14 [00008121114]

Pristiq Extended-Release TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021992
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-05-01

NDC 0008-1211-30 [00008121130]

Pristiq Extended-Release TABLET, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA021992
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-05-01

Drug Details

Active Ingredients

IngredientStrength
DESVENLAFAXINE SUCCINATE50 mg/1

OpenFDA Data

SPL SET ID:0f43610c-f290-46ea-d186-4f998ed99fce
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1874553
  • 1607619
  • 1607617
  • 1874559
  • 790267
  • 790290
    • UPC Code
  • 0300081211303
  • 0300081222309
  • 0300081210306

    • Pharmacological Class

    • Norepinephrine Uptake Inhibitors [MoA]
    • Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    • Serotonin Uptake Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]

    NDC Crossover Matching brand name "Pristiq Extended-Release" or generic name "Desvenlafaxine Succinate"

    NDCBrand NameGeneric Name
    46708-540DesvenlafaxineDesvenlafaxine Succinate
    46708-541DesvenlafaxineDesvenlafaxine Succinate
    46708-542DesvenlafaxineDesvenlafaxine Succinate
    50090-5274DesvenlafaxineDesvenlafaxine Succinate
    50090-5293DesvenlafaxineDesvenlafaxine Succinate
    51991-006DesvenlafaxineDesvenlafaxine Succinate
    51991-311DesvenlafaxineDesvenlafaxine Succinate
    51991-312DesvenlafaxineDesvenlafaxine Succinate
    55700-577DesvenlafaxineDesvenlafaxine Succinate
    50090-4069Desvenlafaxine Succinatedesvenlafaxine succinate
    59762-1210Desvenlafaxine Succinatedesvenlafaxine succinate
    0008-1210Pristiqdesvenlafaxine succinate
    0008-1211Pristiqdesvenlafaxine succinate
    0008-1222Pristiqdesvenlafaxine succinate
    35356-491Pristiqdesvenlafaxine succinate
    43063-262Pristiqdesvenlafaxine succinate
    55154-4230Pristiqdesvenlafaxine succinate
    55154-4235Pristiqdesvenlafaxine succinate

    Trademark Results [Pristiq]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PRISTIQ
    PRISTIQ
    88308904 5828994 Live/Registered
    Wyeth LLC
    2019-02-20
    PRISTIQ
    PRISTIQ
    78541902 3477940 Live/Registered
    WYETH LLC
    2005-01-04
    PRISTIQ
    PRISTIQ
    77200228 3521683 Live/Registered
    WYETH LLC
    2007-06-07
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.